Indag Rubber Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 1, 2025, 5:58 pm

Quick Insight

Indag Rubber Ltd, currently trading at ₹132 with a market capitalization of ₹347 crore, presents a complex investment case. The company's price-to-earnings (P/E) ratio of 74.3 suggests that investors are paying a premium for future earnings, yet the return on equity (ROE) of 2.06% and return on capital employed (ROCE) of 2.93% indicate suboptimal profitability. With an operating profit margin (OPM) of -0.53%, Indag is struggling with operational efficiency. Despite a healthy interest coverage ratio (ICR) of 13.74x and manageable borrowings of ₹9 crore, the absence of institutional investment (FIIs and DIIs both at 0%) raises concerns about market confidence. Given these factors, potential investors should approach with caution, as the high valuation may not be justified by the underlying financials.

Competitors of Indag Rubber Ltd

All Competitor Stocks of Indag Rubber Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:38 am

Below is a detailed analysis of the quarterly data for Indag Rubber Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 55.07 Cr.. The value appears to be declining and may need further review. It has decreased from 55.69 Cr. (Dec 2024) to 55.07 Cr., marking a decrease of 0.62 Cr..
• For Expenses, as of Mar 2025, the value is 55.36 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 56.02 Cr. (Dec 2024) to 55.36 Cr., marking a decrease of 0.66 Cr..
• For Operating Profit, as of Mar 2025, the value is -0.29 Cr.. The value appears strong and on an upward trend. It has increased from -0.33 Cr. (Dec 2024) to -0.29 Cr., marking an increase of 0.04 Cr..
• For OPM %, as of Mar 2025, the value is -0.53%. The value appears strong and on an upward trend. It has increased from -0.59% (Dec 2024) to -0.53%, marking an increase of 0.06%.
• For Other Income, as of Mar 2025, the value is 2.71 Cr.. The value appears strong and on an upward trend. It has increased from 2.58 Cr. (Dec 2024) to 2.71 Cr., marking an increase of 0.13 Cr..
• For Interest, as of Mar 2025, the value is 0.23 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.25 Cr. (Dec 2024) to 0.23 Cr., marking a decrease of 0.02 Cr..
• For Depreciation, as of Mar 2025, the value is 1.66 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.68 Cr. (Dec 2024) to 1.66 Cr., marking a decrease of 0.02 Cr..
• For Profit before tax, as of Mar 2025, the value is 0.53 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Dec 2024) to 0.53 Cr., marking an increase of 0.21 Cr..
• For Tax %, as of Mar 2025, the value is 1.89%. The value appears to be improving (decreasing) as expected. It has decreased from 62.50% (Dec 2024) to 1.89%, marking a decrease of 60.61%.
• For Net Profit, as of Mar 2025, the value is 0.51 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Dec 2024) to 0.51 Cr., marking an increase of 0.38 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.41. The value appears strong and on an upward trend. It has increased from 0.18 (Dec 2024) to 0.41, marking an increase of 0.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:08 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:03 pm

Below is a detailed analysis of the balance sheet data for Indag Rubber Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.00 Cr..
• For Reserves, as of Mar 2025, the value is 222.00 Cr.. The value appears strong and on an upward trend. It has increased from 221.00 Cr. (Mar 2024) to 222.00 Cr., marking an increase of 1.00 Cr..
• For Borrowings, as of Mar 2025, the value is 9.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 10.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 37.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.00 Cr. (Mar 2024) to 37.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 274.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 271.00 Cr. (Mar 2024) to 274.00 Cr., marking an increase of 3.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 60.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2024) to 60.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 128.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 6.00 Cr..
• For Other Assets, as of Mar 2025, the value is 86.00 Cr.. The value appears strong and on an upward trend. It has increased from 85.00 Cr. (Mar 2024) to 86.00 Cr., marking an increase of 1.00 Cr..
• For Total Assets, as of Mar 2025, the value is 274.00 Cr.. The value appears strong and on an upward trend. It has increased from 271.00 Cr. (Mar 2024) to 274.00 Cr., marking an increase of 3.00 Cr..

Notably, the Reserves (222.00 Cr.) exceed the Borrowings (9.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Indag Rubber Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 6.15 (Mar 24) to 2.49, marking a decrease of 3.66.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 6.15 (Mar 24) to 2.49, marking a decrease of 3.66.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has decreased from 7.96 (Mar 24) to 4.32, marking a decrease of 3.64.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 86.70. It has decreased from 87.46 (Mar 24) to 86.70, marking a decrease of 0.76.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 86.70. It has decreased from 87.46 (Mar 24) to 86.70, marking a decrease of 0.76.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 87.02. It has decreased from 95.69 (Mar 24) to 87.02, marking a decrease of 8.67.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. It has decreased from 10.08 (Mar 24) to 5.17, marking a decrease of 4.91.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.65. This value is within the healthy range. It has decreased from 8.06 (Mar 24) to 2.65, marking a decrease of 5.41.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.27. This value is within the healthy range. It has decreased from 7.79 (Mar 24) to 2.27, marking a decrease of 5.52.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 2. It has decreased from 5.94 (Mar 24) to 1.80, marking a decrease of 4.14.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.49. This value is within the healthy range. It has decreased from 6.15 (Mar 24) to 2.49, marking a decrease of 3.66.
• For PBDIT Margin (%), as of Mar 25, the value is 5.93. This value is below the healthy minimum of 10. It has decreased from 10.53 (Mar 24) to 5.93, marking a decrease of 4.60.
• For PBIT Margin (%), as of Mar 25, the value is 3.03. This value is below the healthy minimum of 10. It has decreased from 8.42 (Mar 24) to 3.03, marking a decrease of 5.39.
• For PBT Margin (%), as of Mar 25, the value is 2.60. This value is below the healthy minimum of 10. It has decreased from 8.14 (Mar 24) to 2.60, marking a decrease of 5.54.
• For Net Profit Margin (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 5. It has decreased from 6.20 (Mar 24) to 2.06, marking a decrease of 4.14.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.85. This value is below the healthy minimum of 8. It has decreased from 6.43 (Mar 24) to 2.85, marking a decrease of 3.58.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 15. It has decreased from 7.14 (Mar 24) to 2.86, marking a decrease of 4.28.
• For Return on Capital Employeed (%), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 10. It has decreased from 8.69 (Mar 24) to 2.83, marking a decrease of 5.86.
• For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has decreased from 5.94 (Mar 24) to 2.37, marking a decrease of 3.57.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has increased from 0.00 (Mar 24) to 0.83, marking an increase of 0.83.
• For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has increased from 3.52 (Mar 24) to 3.82, marking an increase of 0.30.
• For Quick Ratio (X), as of Mar 25, the value is 2.30. This value exceeds the healthy maximum of 2. It has increased from 2.09 (Mar 24) to 2.30, marking an increase of 0.21.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.69. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 3.69, marking an increase of 3.69.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 38.99 (Mar 24) to 0.00, marking a decrease of 38.99.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 29.36 (Mar 24) to 0.00, marking a decrease of 29.36.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 61.01 (Mar 24) to 0.00, marking a decrease of 61.01.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 70.64 (Mar 24) to 0.00, marking a decrease of 70.64.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 13.74. This value is within the healthy range. It has decreased from 37.44 (Mar 24) to 13.74, marking a decrease of 23.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.78. This value is within the healthy range. It has decreased from 23.06 (Mar 24) to 5.78, marking a decrease of 17.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 315.77. It has decreased from 352.97 (Mar 24) to 315.77, marking a decrease of 37.20.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.41 (Mar 24) to 1.38, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 23.28. This value exceeds the healthy maximum of 15. It has increased from 13.34 (Mar 24) to 23.28, marking an increase of 9.94.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.38, marking a decrease of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 61.00 (Mar 24) to 0.00, marking a decrease of 61.00.
• For Price / BV (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.38, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.38, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness